Protective effects of Chinese traditional medicine Buyang Huanwu Decoction on myocardial injury

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Lin, Rong ^a   Yang, Guangde ^a   Fang, Zhiyuan ^a,b   Liu, Yu ^a   Zhang, Hui ^a   Shi, Xiaolian ^a   Ji, Qiaoli ^a   Lin, Qinqin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BUYANG HUANWU DECOCTION; CARDIOVASCULAR AGENT; CD40 LIGAND; CHINESE DRUG; CISPLATIN; CREATINE KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPRENALINE; LACTATE DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

EID: 80052698839     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep013     Document Type: Article

References (38)

1. Jugdutt B. I., Nitric oxide and cardioprotection during ischemia-reperfusion Heart Failure Reviews 2002 7 391 405 (Pubitemid 35396471)
2. Balligand J.-L., Ungureanu D., Kelly R. A., Kobzik L., Pimental D., Michel T., Smith T. W., Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium The Journal of Clinical Investigation 1993 91 5 2314 2319 (Pubitemid 23141511)
3. Wildhirt S. M., Weismueller S., Schulze C., Conrad N., Kornberg A., Reichart B., Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovascular Research 1999 43 698 711 (Pubitemid 29369268)
4. Arstall M. A., Sawyer D. B., Fukazawa R., Kelly R. A., Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation Circulation Research 1999 85 829 840 (Pubitemid 29504158)
5. Shah P. K., Circulating markers of inflammation for vascular risk prediction: are they ready for prime time Circulation 2000 101 15 1758 1759 (Pubitemid 30213093)
6. Lombardi F., Tundo F., Terranova P., Battezzati P. M., Ramella M., Bestetti A., Tagliabue L., Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia International Journal of Cardiology 2005 98 2 313 317 (Pubitemid 40431180)
7. Armstrong E. J., Morrow D. A., Sabatine M. S., Inflammatory biomarkers in acute coronary syndromespart II: acute-phase reactants and biomarkers of endothelial cell activation Circulation 2006 113 7 e152 e155
8. Lutgens E., Daemen M. J. A. P., CD40-CD40L interactions in atherosclerosis Trends in Cardiovascular Medicine 2002 12 1 27 32 (Pubitemid 34055720)
9. Tanne D., Haim M., Goldbourt U., Boyko V., Reshef T., Adler Y., Benderly M., Mekori Y. A., Behar S., CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart diseaseB International Journal of Cardiology 2006 107 3 322 326 (Pubitemid 43287775)
10. Tian Y., Li L., Wang R., Ji L., Compound danshen dropping pills: an overview of its protective effect on heart Acta Chinese Medicine and Pharmacology 2005 33 60 61
11. Chen A., Wang H., Zhang J., Wu X., Liao J., Li H., Cai W., Luo X., Ju G., BYHWD rescues axotomized neurons and promotes functional recovery after spinal cord injury in rats Journal of Ethnopharmacology 2008 117 3 451 456
12. Sun X., Zhao Y., Xie X., Cai Y., Zheng Y., Effect of Buyanghuanwu recipe on the expression of inducible nitric oxide synthase in atherosclerosis mice Pharmacology and Clinical Application of Chinese Materia Medica 2006 22 9 11
13. Wei L., Ding S., Therapeutic effect of improved Buyang Huanwu Decoction (decocted in wine) on coronary artery disease Journal of Shandong University of Traditional Chinese Medicine 2002 26 372 374
14. Wu Y., Jiang L., Clinical study on influence of Buyang Huanwu Decoction on the metabolic imbalance of endothelin and calcitonin gene related peptide in patients with early cerebral infarction Chinese Journal of Integrated Traditional and Western Medicine 2000 6 112 115
15. Zhang H., Liang M., Ma Z., Ye S., Clinical study on effects of Buyang Huanwu Decoction on coronary heart disease Chinese Journal of Integrated Traditional and Western Medicine 1996 2 42 4
16. Zhang J., Li C., Guo X., Wang Y., Influence of Buyang Huanwu Decoction on activity of blood platelet activating factor receptor in rabbit Chinese Journal of Integrated Traditional and Western Medicine 1999 5 288 90
17. Wang M., Deng C., Overview and prospect of anti-cerebral ischemia research of Buyang Huanwu Decoction Journal of Hunan College of Traditional Chinese Medicine 2000 20 71 2
18. Wang J., Treatment of 60 cases of angina with improved Buyang Huanwu Decoction Practice of Traditional Chinese Internal Medicine 2006 20 167 8
19. Zeng F., Application of Buyang Huanwu Decoction in cardiovascular and peripheral vascular disease Practice of Traditional Chinese Internal Medicine 2007 21 66 67
20. Guo J., Electrocardiogram of acute coronary syndrome Journal of Clinical Eletrocardiology 2006 15 128 137
21. Guo J., Electrocardiogram of myocardium reperfusion Journal of Clinical Eletrocardiology 2006 15 57 65
22. Huang Z., Clinical meaning of ST Segment descending Journal of Clinical Eletrocardiology 2005 14 165 166
23. Xu S., Experimental Method of Pharmacology 1991 2nd Beijing, China Health Publishing House
24. Howard-Alpe G. M., Sear J. W., Foex P., Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers British Journal of Anaesthesia 2006 97 6 758 769 (Pubitemid 44823659)
25. Razavi H. M., Hamilton J. A., Feng Q., Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure Pharmacology and Therapeutics 2005 106 2 147 162 (Pubitemid 40613056)
26. Kelly R. A., Balligand J.-L., Smith T. W., Nitric oxide and cardiac function Circulation Research 1996 79 3 363 380 (Pubitemid 26276897)
27. Haywood G. A., Tsao P. S., von der Leyen H. E., Mann M. J., Keeling P. J., Trindade P. T., Lewis N. P., Byrne C. D., Rickenbacher P. R., Bishopric N. H., Cooke J. P., McKenna W. J., Fowler M. B., Expression of inducible nitric oxide synthase in human heart failure Circulation 1996 93 6 1087 1094 (Pubitemid 26087012)
28. Mungrue I. N., Gros R., You X., Pirani A., Azad A., Csont T., Schulz R., Butany J., Stewartand D. J., Husain M., Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death The Journal of Clinical Investigation 2002 109 6 735 743 (Pubitemid 34263150)
29. Li D., Qu Y., Tao L., Liu H., Hu A., Gao F., Sharifi-Azad S., Grunwald Z., Ma X.-L., Sun J.-Z., Inhibition of iNOS protects the aging heart against -adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury Journal of Surgical Research 2006 131 1 64 72 (Pubitemid 43227585)
30. Saito T., Hu F., Tayara L., Fahas L., Shennib H., Giaid A., Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure American Journal of Physiology 2002 283 1 H339 H345
31. Hu A., Jiao X., Gao E., Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress Journal of Pharmacology and Experimental Therapeutics 2006 318 469 475 (Pubitemid 44061219)
32. Feng Q., Lu X., Jones D. L., Shen J., Arnold J. M., Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice Circulation 2001 104 700 704 (Pubitemid 32738526)
33. Li J.-J., Silent myocardial ischemia may be related to inflammatory response Medical Hypotheses 2004 62 2 252 256 (Pubitemid 38253393)
34. Pasqui A. L., Di Renzo M., Bova G., Maffei S., Pompella G., Auteri A., Puccetti L., Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes Clinical and Experimental Medicine 2006 6 1 38 44
35. Suzuki J., Ogawa M., Maejima Y., Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats Journal of Molecular and Cellular Cardiology 2007 42 432 440 (Pubitemid 46135601)
36. Malarstig A., Lindahl B., Wallentin L., Siegbahn A., Soluble CD40L levels are regulated by the -3459 A G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 1667 1673 (Pubitemid 44288999)
37. Bingaman A. W., Pearson T. C., Larsen C. P., The role of CD40L in T cell-dependent nitric oxide production by murine macrophages Transplant Immunology 2000 8 3 195 202 (Pubitemid 32010882)
38. Al-Ramadi B. K., Fernandez-Cabezudo M. J., Ullah A., El-Hasasna H., Flavell R. A., CD154 is essential for protective immunity in experimental Salmonella infection: evidence for a dual role in innate and adaptive immune responses The Journal of Immunology 2006 176 1 496 506 (Pubitemid 43023296)